A detailed history of Black Rock Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,965,806 shares of KURA stock, worth $62.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,965,806
Previous 6,899,369 0.96%
Holding current value
$62.8 Million
Previous $147 Million 2.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.53 - $22.98 $1.16 Million - $1.53 Million
66,437 Added 0.96%
6,965,806 $143 Million
Q1 2024

May 10, 2024

SELL
$13.42 - $23.53 $5.59 Million - $9.8 Million
-416,278 Reduced 5.69%
6,899,369 $147 Million
Q4 2023

Feb 13, 2024

BUY
$7.58 - $14.38 $2.99 Million - $5.67 Million
394,602 Added 5.7%
7,315,647 $105 Million
Q3 2023

Nov 13, 2023

BUY
$8.44 - $11.86 $6.45 Million - $9.06 Million
763,643 Added 12.4%
6,921,045 $63.1 Million
Q2 2023

Aug 11, 2023

BUY
$9.62 - $13.99 $7.58 Million - $11 Million
788,095 Added 14.68%
6,157,402 $65.1 Million
Q1 2023

May 12, 2023

BUY
$10.71 - $14.6 $2.21 Million - $3.01 Million
206,471 Added 4.0%
5,369,307 $65.7 Million
Q4 2022

Feb 13, 2023

BUY
$11.23 - $16.9 $3.18 Million - $4.79 Million
283,528 Added 5.81%
5,162,836 $64.1 Million
Q3 2022

Nov 14, 2022

SELL
$12.01 - $19.45 $994,199 - $1.61 Million
-82,781 Reduced 1.67%
4,879,308 $66.7 Million
Q2 2022

Aug 12, 2022

BUY
$10.71 - $18.33 $157,908 - $270,257
14,744 Added 0.3%
4,962,089 $91 Million
Q1 2022

May 12, 2022

SELL
$11.78 - $16.98 $1.74 Million - $2.51 Million
-147,681 Reduced 2.9%
4,947,345 $79.6 Million
Q4 2021

Feb 10, 2022

BUY
$12.22 - $19.57 $1.14 Million - $1.83 Million
93,610 Added 1.87%
5,095,026 $71.3 Million
Q3 2021

Nov 09, 2021

BUY
$15.42 - $21.72 $601,919 - $847,840
39,035 Added 0.79%
5,001,416 $93.7 Million
Q2 2021

Aug 11, 2021

BUY
$20.85 - $29.88 $103 Million - $148 Million
4,962,381 New
4,962,381 $103 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.